Tag:

Immunovaccine

Latest Headlines

Latest Headlines

Glaxo's Ebola vaccine trial set to begin in September

August 28, 2014 | By
As the Ebola outbreak continues to claim victims in West Africa, governments and industry alike are racing toward a therapeutic or preventive drug that could help halt its deadly spread and avert future human crises involving the virus.

Passive vaccine could treat cocaine overdose

April 19, 2012 | By
Scripps Research Institute is developing a passive vaccine to treat cocaine overdose and has seen promising results in animals.

DepoVax drug and vaccine combination cuts tumor immunosuppression

April 5, 2012 | By
Part of the success of some cancers is that they can avoid an immune response, and this can also cut the response to vaccines. Immunovaccine is developing a comeback to this--suppress the suppression.

Immunovaccine to focus on ovarian cancer

November 19, 2010 | By
Halifax, Nova Scotia-based Immunovaccine will focus the Phase I/II clinical development plan for DPX-Survivac on ovarian cancer. The decision is based on positive input from leaders in cancer
Related Tags
Press Releases
  • Sucampo and Takeda Launch Direct-to-Consumer Advertising Campaign for AMITIZA(R) (lubiprostone) for Chronic Idiopathic Constipation
  • NIH awards initial $46 million for BRAIN Initiative research
  • TransEnterix, Inc. Secures up to $25 Million in Growth Capital from Oxford Finance and Silicon Valley Bank
  • Sarepta Therapeutics Announces Favorable Safety Results from Phase I Clinical Study of Influenza Drug Candidate
  • Pfizer And Kyowa Hakko Kirin To Collaborate On Immuno-Oncology Combination Study
  • More Press Releases
Sponsored Links